Bolt Biotherapeutics, Inc., based in the San Francisco Bay Area, is a publicly-traded biotechnology company developing Boltbody™ Immune-stimulating Antibody Conjugates (ISAC), a new class of immuno-oncology therapeutics that have eliminated tumors following systemic administration in preclinical studies and results in the development of immunological memory, which may lead to more durable clinical responses for patients. Bolt’s technology is appropriate for a broad spectrum of antibodies targeting tumor antigens expressed on all types of cancer and therefore applicable to many types of patients, including those who are refractory to the current generation of checkpoint inhibitors. The company is led by a team with extensive oncology drug discovery and development experience. Bolt was founded by Dr. Ed Engleman, and its platform is based on technology exclusively licensed from Stanford University. The company is financed by world-class investors including Novo Holdings, Pivotal bioVenture Partners, Vivo Capital and Nan Fung Life Sciences. For more information about Bolt Biotherapeutics, please visit www.boltbio.com.
View Top Employees from Bolt Biotherapeutics, Inc.Website | http://boltbio.com/ |
Ticker | BOLT |
Revenue | $21 million |
Funding | $340.5 million |
Employees | 108 (104 on RocketReach) |
Founded | 2015 |
Address | 900 CHESAPEAKE DRIVE, Redwood City, California 94063, US |
Phone | (650) 665-9295 |
Technologies |
JavaScript,
HTML,
PHP
+35 more
(view full list)
|
Industry | Biotechnology, Drug Manufacturing & Research, Pharmaceuticals, Science and Engineering, Healthcare, Medical, Health Care, Pharmaceutical |
Keywords | Biotechnology, Cancer Treatment, Immuno-Oncology, Preclinical Research |
Competitors | Arcus Biosciences, INmune Bio Inc., Sensei Bio, Turnstone Biologics, iTeos Therapeutics |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies |
Looking for a particular Bolt Biotherapeutics, Inc. employee's phone or email?
The Bolt Biotherapeutics, Inc. annual revenue was $21 million in 2024.
Willie Quinn is the CFO of Bolt Biotherapeutics, Inc..
104 people are employed at Bolt Biotherapeutics, Inc..
Bolt Biotherapeutics, Inc. is based in Redwood City, California.
The NAICS codes for Bolt Biotherapeutics, Inc. are [54, 541, 32541, 32, 325, 3254].
The SIC codes for Bolt Biotherapeutics, Inc. are [28, 283].